399 related articles for article (PubMed ID: 12967321)
1. Statins reduce oxidized low-density lipoprotein levels, but do not alter soluble intercellular cell-adhesion molecule-1 and vascular cell-adhesion molecule-1 levels in subjects with hypercholesterolaemia.
Rosenson RS; Wolff D; Tangney CC
Clin Sci (Lond); 2004 Feb; 106(2):215-7. PubMed ID: 12967321
[TBL] [Abstract][Full Text] [Related]
2. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations.
Miles EA; Thies F; Wallace FA; Powell JR; Hurst TL; Newsholme EA; Calder PC
Clin Sci (Lond); 2001 Jan; 100(1):91-100. PubMed ID: 11115423
[TBL] [Abstract][Full Text] [Related]
3. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
[TBL] [Abstract][Full Text] [Related]
4. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
[TBL] [Abstract][Full Text] [Related]
5. Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.
Bleske BE; Nicklas JM; Bard RL; Brook RD; Gurbel PA; Bliden KP; Rajagopalan S; Pitt B
J Am Coll Cardiol; 2006 Jan; 47(2):338-41. PubMed ID: 16412857
[TBL] [Abstract][Full Text] [Related]
6. Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemia.
Jilma B; Joukhadar C; Derhaschnig U; Rassoul F; Richter V; Wolzt M; Dorner GT; Petternel V; Wagner OF
Clin Sci (Lond); 2003 Feb; 104(2):189-93. PubMed ID: 12546641
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of serum levels of adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) in stable and unstable angina and acute myocardial infarction].
Bossowska A; Kiersnowska-Rogowska B; Bossowski A; Galar B; Sowiński P
Przegl Lek; 2003; 60(7):445-50. PubMed ID: 14750416
[TBL] [Abstract][Full Text] [Related]
8. Association between reduced low density lipoprotein oxidation and inhibition of monocyte chemoattractant protein-1 production in statin-treated subjects.
Rosenson RS; Tangney CC; Levine DM; Parker TS; Gordon BR
J Lab Clin Med; 2005 Feb; 145(2):83-7. PubMed ID: 15746650
[TBL] [Abstract][Full Text] [Related]
9. [Relation of the soluble cytoadhesion molecules VCAM-1 and ICAM-1 to selected clinical and laboratory indicators in multiple myeloma].
Scudla V; Budíková M; Bacovský J; Ordeltová M; Opíchalová D; Heincová V
Vnitr Lek; 1999 Oct; 45(10):583-90. PubMed ID: 10951865
[TBL] [Abstract][Full Text] [Related]
10. Does vitamin C supplementation influence the levels of circulating oxidized LDL, sICAM-1, sVCAM-1 and vWF-antigen in healthy male smokers?
Van Hoydonck PG; Schouten EG; Manuel-Y-Keenoy B; van Campenhout A; Hoppenbrouwers KP; Temme EH
Eur J Clin Nutr; 2004 Dec; 58(12):1587-93. PubMed ID: 15127090
[TBL] [Abstract][Full Text] [Related]
11. Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events.
Blann AD; Seigneur M; Steiner M; Miller JP; McCollum CN
Thromb Haemost; 1998 Jun; 79(6):1080-5. PubMed ID: 9657427
[TBL] [Abstract][Full Text] [Related]
12. Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia.
Nawawi H; Osman NS; Yusoff K; Khalid BA
Horm Metab Res; 2003 Aug; 35(8):479-85. PubMed ID: 12953165
[TBL] [Abstract][Full Text] [Related]
13. Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial.
Conen D; Everett BM; Glynn RJ; Ridker PM
Heart; 2008 Mar; 94(3):e13. PubMed ID: 17923463
[TBL] [Abstract][Full Text] [Related]
14. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
Bays HE; Davidson M; Jones MR; Abby SL
Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
[TBL] [Abstract][Full Text] [Related]
15. Elevated soluble intercellular adhesion molecule-1 levels in patients with systemic lupus erythematosus: relation to insulin resistance.
Tso TK; Huang WN
J Rheumatol; 2007 Apr; 34(4):726-30. PubMed ID: 17309130
[TBL] [Abstract][Full Text] [Related]
16. Effect of allergen immunotherapy on soluble adhesion molecules.
Pereira-Santos MC; Pregal AL; Spínola-Santos A; Alonso E; Palma-Carlos ML; Palma-Carlos AG
Allerg Immunol (Paris); 2001 Jun; 33(6):225-8. PubMed ID: 11505805
[TBL] [Abstract][Full Text] [Related]
17. Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis.
John S; Jacobi J; Delles C; Schlaich MP; Alter O; Schmieder RE
Clin Sci (Lond); 2000 May; 98(5):521-9. PubMed ID: 10781382
[TBL] [Abstract][Full Text] [Related]
18. Soluble endothelial cell adhesion molecules and their relationship to disease activity in Takayasu's arteritis.
Tripathy NK; Chandran V; Garg NK; Sinha N; Nityanand S
J Rheumatol; 2008 Sep; 35(9):1842-5. PubMed ID: 18597403
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
Conran N; Fattori A; Saad ST; Costa FF
Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
[TBL] [Abstract][Full Text] [Related]
20. Oxidized-LDL levels are changed during short-term serum glucose variations and lowered with statin treatment in early Type 2 diabetes: a study of endothelial function and microalbuminuria.
Paniagua JA; López-Miranda J; Pérez-Martínez P; Marín C; Vida JM; Fuentes F; Fernández de la Puebla RA; Pérez-Jiménez F
Diabet Med; 2005 Dec; 22(12):1647-56. PubMed ID: 16401307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
